Literature DB >> 25715887

Guideline of Guidelines: Imaging of Localized Prostate Cancer.

Daniel A Wollin1, Danil V Makarov2,3,4,5,6.   

Abstract

Entities:  

Keywords:  guidelines; imaging; prostate; prostate cancer; screening

Mesh：

Year:  2015        PMID： 25715887      PMCID： PMC4768736          DOI： 10.1111/bju.13104

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  7 in total

1.  EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

Authors:  Axel Heidenreich; Patrick J Bastian; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Theodor van der Kwast; Malcolm Mason; Vsevolod Matveev; Thomas Wiegel; F Zattoni; Nicolas Mottet
Journal:  Eur Urol       Date:  2013-10-06       Impact factor: 20.096

Review 2.  Quality indicators in radiation oncology.

Authors:  Jeffrey M Albert; Prajnan Das
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-03       Impact factor: 7.038

3.  The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population.

Authors:  Danil V Makarov; Rani A Desai; James B Yu; Richa Sharma; Nitya Abraham; Peter C Albertsen; David F Penson; Cary P Gross
Journal:  J Urol       Date:  2011-11-16       Impact factor: 7.450

4.  Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat.

Authors:  Danil V Makarov; Rani Desai; James B Yu; Richa Sharma; Nitya Abraham; Peter C Albertsen; Harlan M Krumholz; David F Penson; Cary P Gross
Journal:  Health Aff (Millwood)       Date:  2012-04       Impact factor: 6.301

5.  ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance.

Authors:  Steven C Eberhardt; Scott Carter; David D Casalino; Gregory Merrick; Steven J Frank; Alexander R Gottschalk; John R Leyendecker; Paul L Nguyen; Aytekin Oto; Christopher Porter; Erick M Remer; Seth A Rosenthal
Journal:  J Am Coll Radiol       Date:  2013-02       Impact factor: 5.532

6.  The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.

Authors:  Matthew R Cooperberg; Deborah P Lubeck; Maxwell V Meng; Shilpa S Mehta; Peter R Carroll
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

7.  Prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imaging.

Authors:  Danil V Makarov; Stacy Loeb; David Ulmert; Linda Drevin; Mats Lambe; Pär Stattin
Journal:  J Natl Cancer Inst       Date:  2013-07-23       Impact factor: 13.506
  7 in total
  4 in total

1.  Use of Evidence-Based Prostate Cancer Imaging in a Nongovernmental Integrated Health Care System.

Authors:  Ramzi G Salloum; Maureen O'Keeffe-Rosetti; Debra P Ritzwoller; Mark C Hornbrook; Jennifer Elston Lafata; Matthew E Nielsen
Journal:  J Oncol Pract       Date:  2017-02-21       Impact factor: 3.840

2.  A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer.

Authors:  Danil V Makarov; Erica Sedlander; R Scott Braithwaite; Scott E Sherman; Steven Zeliadt; Cary P Gross; Caitlin Curnyn; Michele Shedlin
Journal:  Implement Sci       Date:  2016-09-02       Impact factor: 7.327

3.  Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop.

Authors:  Manoj Gupta; Partha Sarathi Choudhury; Sudhir Rawal; Harish Chandra Goel; Vineet Talwar; Amitabh Singh; Saroj Kumar Sahoo
Journal:  World J Nucl Med       Date:  2018 Oct-Dec

4.  United in Fight against prOstate cancer (UFO) registry: first results from a large, multi-centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia.

Authors:  Hirotsugu Uemura; Dingwei Ye; Ravindran Kanesvaran; Edmund Chiong; Bannakij Lojanapiwat; Yeong-Shiau Pu; Sudhir Kumar Rawal; Azad Hassan Abdul Razack; Hao Zeng; Byung Ha Chung; Noor Ashani Md Yusoff; Chikara Ohyama; Choung Soo Kim; Sunai Leewansangtong; Yuh-Shyan Tsai; Yanfang Liu; Weiping Liu; Maximiliano van Kooten Losio; Marxengel Asinas-Tan
Journal:  BJU Int       Date:  2020-01-30       Impact factor: 5.588
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.